- Funds
- Insights
- Capabilities
- Sustainability
- About Us
- My Account
Singapore, Institutional
ChangeWellSaid: Partnering with portfolio companies
Co-head of private investing Michael Carmen explores how we partner with portfolio companies to help them along the "last mile from the private market to the public market" including on key ESG issues for private companies to consider.
Private biotech market: Innovation, valuations, and capital efficiency
Co-heads of biotech private investments I-hung Shih and Nilesh Kumar join host Thomas Mucha to explore today's private biotech market, highlighting the state of deal flow, valuations, and innovation.
Private market perspectives
We share insights from our private market experts in early-stage diverse venture, multi-stage climate, late-stage biomed, late-stage diversified growth, and ESG in private markets.
URL References
Related Insights